- Exchange: NASDAQ GM
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
ACADIA Pharmaceuticals Inc+ Add to Watchlist
ACAD:US13.7900 USD 0.3600 2.54%
As of 20:10:00 ET on 05/21/2013.
Company Profile for ACADIA Pharmaceuticals Inc (ACAD)
ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs for the treatment of central nervous system disorders. The company is currently working on the treatment of induced dysfunction in Parkinson's disease ,schizophrenia, neuropathic pain and glaucoma.
ACADIA Pharmaceuticals Inc
Key Executives for ACADIA Pharmaceuticals Inc (ACAD)
|Uli HacksellPresident/CEO||Thomas H AasenExec VP/CFO/Treasurer|
|Roger M MillsExec VP:Dev/Chief Medical Ofcr||Glenn F BaityVP/Secy/General Counsel|
|Lisa BarthelemyDirector:Investor Relations|